rev1 engineering and filmecc- medical device design and manufacturing logo

Rev.1 Engineering: The Flexible R&D Team You Need

If you are intrigued by the concept of running your start-up company as a “virtual entity” with low fixed costs and low capital expenditure, you need a medical device development firm that shares your vision.

Or perhaps you are a VP of R&D at an established company in need of extra help with device development, or maybe you have a project that’s been on the back burner for far too long. You need an outsource solution that can seamlessly integrate with your existing team and be trusted to deliver results.

Rev.1 Engineering has been built from the ground up to own and deliver every step of medical device product development from innovation through to the manufacturing stage and to do it by seamlessly integrating into your corporation as your R&D team.

Start-up companies bring us in as their development partner so they can concentrate on other corporate strategies and duties. CEO’s of new companies have plenty to do without worrying about R&D hiring, project management and resource allocation. By using Rev.1 as their R&D team, they know they have access to a breadth of talents, exactly when they need them to meet the next milestone.

Established companies bring us in on projects when the job is outside their realm of expertise or their in-house capacity is maxed out on other projects. Rev.1’s range of capabilities and flexibility makes us a natural fit for mature companies. We easily integrate ourselves with an existing team, facilitating easy and thorough communications. Or, we can take on an entire project, from start to finish, with our team working on all facets.

Don’t wait to get your project started. Rev.1 Engineering will move your development 2x Faster than it would take with a start-up in-house team. Give us a call at 951.696.3933, connect with us on LinkedIn, or send us an email at info@rev1engineering.com, and we’ll offer you the R&D flexibility you need, whatever your situation.